Inventor · disambiguated record
Arthur Machlenkin
Also filed as: MACHLENKIN ARTHUR
12 granted patents·9 pending applications·35 citations·filing 2003–2024
87Inventor score
Top patents by PatentIndex Score
21 records- 0187US11225523B2Triple combination antibody therapiesCOMPUGEN LTD·Filed 2018·Granted Jan 18, 2022·3 cites·11 claims
- 0284US7960507B2Tumor associated antigen peptides and use of same as anti-tumor vaccinesYEDA RES & DEV·Filed 2010·Granted Jun 14, 2011·4 cites·8 claims
- 0384US7906620B2Tumor associated antigen, peptides thereof, and use of same as anti-tumor vaccinesYEDA RES & DEV·Filed 2003·Granted Mar 15, 2011·19 cites·15 claims
- 0481US2024025973A1Pvrig polypeptides and methods of treatmentCOMPUGEN LTD·Filed 2023·Application pending·0 cites
- 0580US2025136710A1Triple combination antibody therapiesCOMPUGEN LTD·Filed 2024·Application pending·0 cites
- 0679US10064927B2Allogeneic tumor cell vaccinationHADASIT MED RES SERVICE·Filed 2016·Granted Sep 4, 2018·3 cites·13 claims
- 0779US2025288667A1Genetically engineered mucosal-associated invariant t (mait) cells for adoptive transfer celltherapyPLURI BIOTECH LTD·Filed 2024·Application pending·0 cites
- 0878US10550173B2PVRIG polypeptides and methods of treatmentCOMPUGEN LTD·Filed 2016·Granted Feb 4, 2020·2 cites·10 claims
- 0976US2025290039A1Genetically engineered placental mucosalassociated invariant t (mait) cells and uses thereofPLURI BIOTECH LTD·Filed 2024·Application pending·0 cites
- 1074US12152084B2Triple combination antibody therapiesCOMPUGEN LTD·Filed 2021·Granted Nov 26, 2024·0 cites·12 claims
- 1172US2024287174A1Hide1 compositions and methodsCOMPUGEN LTD·Filed 2023·Application pending·0 cites
- 1271US9301998B2Allogeneic tumor cell vaccinationHADASIT MED RES SERVICE·Filed 2013·Granted Apr 5, 2016·1 cites·24 claims
- 1371US8420078B2Methods and immunogenic cell preparations for treating antigen-associated diseasesEISENBACH LEA·Filed 2006·Granted Apr 16, 2013·3 cites·14 claims
- 1470US11795209B2PVRIG polypeptides and methods of treatmentCOMPUGEN LTD·Filed 2020·Granted Oct 24, 2023·0 cites·15 claims
- 1565US2023078665A1Cell compositions and methods for cancer therapyHADASIT MED RES SERVICE·Filed 2022·Application pending·0 cites
- 1660US11530251B2Methods for cancer therapy using isolated NTB-A ectodomain polypeptidesHADASIT MED RES SERVICE·Filed 2019·Granted Dec 20, 2022·0 cites·7 claims
- 1755US12466849B2Anti-viral and anti-tumoral compoundsYEDA RES & DEV·Filed 2022·Granted Nov 11, 2025·0 cites·20 claims
- 1855US2024228521A1Anti-viral and anti-tumoral compounds, and uses thereofYEDA RES & DEV·Filed 2022·Application pending·0 cites
- 1948US2018305451A1Hide1 compositions and methodsCOMPUGEN LTD·Filed 2016·Application pending·0 cites
- 2043US10344073B2Cell compositions and methods for cancer therapyHADASIT MED RES SERVICE·Filed 2015·Granted Jul 9, 2019·0 cites·9 claims
- 2137US2008213237A1Antigen Specific Lymphocytes, Compositions Thereof, and Methods for Isolation and Preparation ThereofHADASIT MED RES SERVICE·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Arthur Machlenkin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →